Article
Cancer Targeting Radiopeptidomimetics in Molecular Nuclear Medicine
13 Mar 2025
Abstract excerpt
Peptides are highly receptor-affine molecules exhibiting suitable pharmacokinetics. Additionally, low-cost production, simple protocols allowing easy modifications, and tolerance toward harsh reaction conditions make peptides ideal ligands for preparation of radiopharmaceuticals for cancer detection and treatment. However, natural peptides being substrates for enzymes are susceptible to proteolysis, which limits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
